ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Triethylamine → 4-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carboxylic acid (4,9-dimethyl-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-cyclohepta[e]inden-7-yl)-amide

HRID 132255
印刷

反応式

HRID 132255 の反応式
Cl.[NH2:2][CH:3]1[C:17](=[O:18])[N:16]([CH3:19])[CH2:15][C:6]2[C:7]3[CH:8]=[N:9][NH:10][C:11]=3[C:12]([CH3:14])=[CH:13][C:5]=2[CH2:4]1.[C:20](=O)(ON1C(=O)CCC1=O)[O:21]N1C(=O)CCC1=O.C(N(CC)CC)C.Cl.[NH:46]1[CH2:51][CH2:50][CH:49]([N:52]2[CH2:61][C:60]3[C:55](=[CH:56][CH:57]=[CH:58][CH:59]=3)[NH:54][C:53]2=[O:62])[CH2:48][CH2:47]1>ClCCl>[CH3:14][C:12]1[C:11]2[NH:10][N:9]=[CH:8][C:7]=2[C:6]2[CH2:15][N:16]([CH3:19])[C:17](=[O:18])[CH:3]([NH:2][C:20]([N:46]3[CH2:47][CH2:48][CH:49]([N:52]4[CH2:61][C:60]5[C:55](=[CH:56][CH:57]=[CH:58][CH:59]=5)[NH:54][C:53]4=[O:62])[CH2:50][CH2:51]3)=[O:21])[CH2:4][C:5]=2[CH:13]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 8471TriethylamineHCID 676246Di(succinimido) carbonateHCID 183213553-(Piperidin-4-yl)-3,4-dihydroquinazolin-2(1H)-one hydrochlorideHCID 1317269227-amino-4,9-dimethyl-6,7,9,10-tetrahydro-3H-2,3,9-triaza-cyclohepta[e]inden-8-one, hydrochloride

生成物 1

HCID 24783417
4-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carboxylic acid (4,9-dimethyl-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-cyclohepta[e]inden-7-yl)-amide

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒

実験手順

To a solution of (4,9-dimethyl-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-cyclohepta[e]inden-7-yl)-carbamic acid benzyl ester (50 mg, 0.132 mmol) in methanol and chloroform (0.5 mL) was added 10% palladium on carbon (20 mg) under nitrogen atmosphere. The reaction mixture was brought to hydrogen atmosphere (1 atm) and stirred for 3 h. The catalyst was filtered and the solvent was evaporated to give 7-amino-4,9-dimethyl-6,7,9,10-tetrahydro-3H-2,3,9-triaza-cyclohepta[e]inden-8-one, hydrochloride in almost quantitative yield. To the amine salt in dichloromethane was added disuccinimidyl carbonate (37 mg, 0.145 mmol) and triethylamine (0.11 mL, 0.8 mmol) at room temperature. After 120 min, 3-piperidin-4-yl-3,4-dihydro-1H-quinazolin-2-one, hydrochloride (39 mg, 0.145 mmol) was added and stirring continued for 12 h. The solvent was evaporated and the crude product was purified by Prep HPLC to give 4-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carboxylic acid (4,9-dimethyl-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-cyclohepta[e]inden-7-yl)-amide in 59% overall yield. MS (ESI) 502 (M+H); Rf=1.31.

後処理

  1. waitcontinued for 12 h
  2. customThe solvent was evaporated
  3. customthe crude product was purified by Prep HPLC

出典と根拠

ORDレコード
ord-6fbb3e7b09384bbf9f757a94d721bd95
出典データセット
uspto-grants-2008_06
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07384930B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート